Ten-year results display strong safety and efficacy profile for TPV device

(Society for Cardiovascular Angiography and Interventions) Ten-year follow-up results of the US Investigational Device Exemption (IDE) Trial of the Melody transcatheter pulmonary valve (TPV) were presented today during the SCAI 2020 Scientific Sessions Virtual Conference. Findings showed favorable outcomes for long-term function, safety, and efficacy for congenital patients who underwent Melody valve implantation within an existing dysfunctional right ventricular outflow tract (RVOT) conduit or bioprosthetic pulmonary valve.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news